Cabug, John Khael M.

HRN: 22-18-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CEFUROXIME 750MG (VIAL)
09/07/2023
09/14/2023
IV
280mg
Q8hours
UTI
Waiting Final Action 
09/10/2023
MEBENDAZOLE 500MG (TAB)
09/10/2023
09/17/2023
IV
85mg
Q8hours
Acute Gastroenteritis
Waiting Final Action 
09/12/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/12/2023
09/17/2023
PO
3.5ml
Q8hours
Acute Gastroenteritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: